Insight Molecular Diagnostics Inc. — Director's Dealing 2025

Jul 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Insight Molecular Diagnostics Inc. (IMDX)
CIK: 0001642380
Period of Report: 2025-07-01

Reporting Person: Arno Andrew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-01	Common Stock, no par value	A	55000	—	Acquired	136554	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, no par value	7804	Indirect
Common Stock, no par value	7804	Indirect

Footnotes

F1: The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

F2: These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.

F3: These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.